iShares Russell 2000 Growth Fund (IWO)

IWO is an iShares fund that does one simple job: it holds the Russell 2000 Growth index, which is all the small-cap stocks in the Russell 2000 that look expensive because the market thinks they will grow fast. These are the flipside of the value index. Value investors buy the beaten-down stocks; growth investors buy the ones everyone is excited about. IWO is for the growth side.

The Russell 2000 Growth includes roughly 1,000 stocks — the smaller-cap half of the stock market, filtered for high growth characteristics. The Russell Company scores all stocks on earnings growth, sales growth, and price-to-book ratios, and the Growth index takes the ones most likely to expand earnings quickly. These are young or newly public firms, disruptive tech or biotech, or established small companies growing faster than their peers.

What growth means here

When Russell labels something “growth,” it does not mean the stock will definitely grow. It means the market is pricing in growth. That is important. A growth stock is expensive relative to its current earnings because investors expect those earnings to expand. If the company then disappoints — the market matures faster than expected, competition appears, management stumbles — the stock will fall sharply. A $100 stock trading at 50x earnings is betting on a future that may not arrive.

IWO holds a lot of those bets. Technology firms trying to disrupt a market, biotech companies chasing the next blockbuster drug, small retailers riding a consumer trend. Many will succeed; many will fail. The fund holds all of them, equally weighted alongside the winners, so IWO’s volatility is inherently higher than an index of cheap, stable, profitable small businesses would be.

The sector tilt

Because growth screens tend to catch fast-expanding sectors, IWO tilts heavily toward technology and health care and away from financials, energy, and utilities. Those last three sectors are generally mature and steady-growing, not fast-growing, so they get underweighted in a growth index. That means IWO is a bet not just on small caps and growth stocks, but also on the sectors the fund’s structure naturally favors.

During the 2010s, when technology and cloud computing and health tech boomed, IWO crushed the value index. During downturns or when those sectors fall out of favour, IWO can lag significantly. It is not a neutral small-cap exposure; it is a directional bet on the future of technology and biotech at the small-cap level.

How IWO behaves across cycles

In bull markets, growth stocks are loved. Investors are willing to pay high prices for earnings growth. IWO tends to outperform. In recessions, the opposite happens. Growth is expensive precisely because the market is paying for future growth. When that future gets clouded by recession, high-multiple growth stocks get punished — sometimes more severely than cheaper value stocks that have less downside room left. From 2000 to 2002, after the dot-com crash, IWO lost roughly 50% because the market repriced growth. From 2008 to 2009, growth took another hit in the financial crisis. From 2022 onward, as interest rates rose, growth again underperformed.

The pattern is reliable enough to matter: growth works in expansions, value works in contractions. IWO is a bet on expansion continuing or returning.

The opportunity and the trap

For long-term investors with patience through downturns, a concentrated bet on growth has historically paid off. The winners in small-cap growth — companies that actually do scale into large firms — can deliver multibagger returns. But individual investors have to stomach the volatility. IWO can fall 50% or more in a prolonged bear market. That requires conviction that you are buying the future, not just the present.

The trap is paying too much for a future that never arrives. A small biotech company trading at infinite price-to-earnings (no earnings yet, just potential) is betting the drug trial succeeds. It might not. Small-cap growth investors are, by definition, buying many such bets. Some will win; others will lose. The fund structure assumes the winners compound enough to cover the losers — which is often true, but not always, and not in every timeframe.

Using IWO

IWO is useful for investors who believe small-cap growth — the futuristic, fast-expanding, expensive end of the small-cap market — will outperform over the next several years, and for those who can tolerate sharp drawdowns. It is also useful as a piece of a diversified portfolio, paired with a value or dividend fund to balance the portfolio’s growth tilt.

The fund’s holdings shift annually with the Russell reconstitution in June. Watching which stocks move into and out of the index reveals which firms the Russell Company no longer sees as growth candidates — either because they have slowed or because they have grown large enough to move into the midcap Russell indices. That migration is often a signal worth watching.

The simplest way to think about IWO: it is the bet on the future you are making when you buy growth stocks, applied to the smallest 2,000 American companies, with no active manager to override the index. You get the growth tilt, the sector skew toward tech and health, and the full volatility. It is straightforward, liquid, and very cheap to own. Whether that bet pays off depends on whether those small-cap growth stocks actually grow.